Wed, November 23, 2016
Tue, November 22, 2016
Mon, November 21, 2016
Fri, November 18, 2016
Thu, November 17, 2016
Wed, November 16, 2016
Tue, November 15, 2016

Debjit Chattopadhyay Initiated (VRTX) at Hold and Held Target at $98 on, Nov 18th, 2016


  Copy link into your clipboard //stocks-investing.news-articles.net/content/201 .. hold-and-held-target-at-98-on-nov-18th-2016.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication
Debjit Chattopadhyay of Janney Montgomery Scott, Initiated "Vertex Pharmaceuticals Incorporated" (VRTX) at Hold and Held Target at $98 on, Nov 18th, 2016.

Debjit has made no other calls on VRTX in the last 4 months.



There are 4 other peers that have a rating on VRTX. Out of the 4 peers that are also analyzing VRTX, 2 agree with Debjit's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Andrew Fein of "HC Wainwright & Co." Downgraded from Strong Buy to Hold on, Monday, October 24th, 2016
  • Christopher Raymond of "Raymond James" Initiated at Hold on, Tuesday, September 13th, 2016


These are the ratings of the 2 analyists that currently disagree with Debjit


  • Biren Amin of "Jefferies" Maintained at Strong Buy with Increased Target to $105 on, Wednesday, October 5th, 2016
  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Decreased Target to $139 on, Thursday, July 28th, 2016

Publication Contributing Sources